AIM2 and breast carcinoma: Research has illuminated that the expression of AIM2 can suppress the proliferation and tumorigenicity of human breast cancer cells through the negative regulation of the TNF-α/NF-κB anti-apoptotic pathway (Figure 3, left panels) (51).